{"id":616277,"date":"2022-09-14T19:58:01","date_gmt":"2022-09-14T19:58:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=616277"},"modified":"2022-09-14T19:58:01","modified_gmt":"2022-09-14T19:58:01","slug":"thyroid-cancer-market-to-grow-at-a-substantial-growth-rate-during-the-forecast-period-20222032-delveinsight-key-companies-novartis-affyimmune-therapeutics-eli-lilly-loxooncology","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/thyroid-cancer-market-to-grow-at-a-substantial-growth-rate-during-the-forecast-period-20222032-delveinsight-key-companies-novartis-affyimmune-therapeutics-eli-lilly-loxooncology_616277.html","title":{"rendered":"Thyroid Cancer Market to Grow at a Substantial Growth Rate During the Forecast Period  (2022-2032) &#8211;  DelveInsight | Key Companies &#8211; Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1663166253.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Thyroid Cancer Market to Grow at a Substantial Growth Rate During the Forecast Period  (2022-2032) -  DelveInsight | Key Companies - Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology\" src=\"https:\/\/www.abnewswire.com\/uploads\/1663166253.jpeg\" alt=\"Thyroid Cancer Market to Grow at a Substantial Growth Rate During the Forecast Period  (2022-2032) -  DelveInsight | Key Companies - Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">DelveInsight\u2019s \u201cThyroid Cancer Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of Thyroid Cancer, historical and forecasted epidemiology as well as the Thyroid Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/div>\n<p style=\"text-align: justify;\">The <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/thyroid-cancer-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Thyroid Cancer market<\/a><\/strong> is expected to surge due to the disease&#8217;s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Thyroid Cancer pipeline products will significantly revolutionize the Thyroid Cancer market dynamics.&nbsp;&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Overview<\/strong><\/p>\n<p style=\"text-align: justify;\">The thyroid, or thyroid gland, is an endocrine gland in the neck. It releases hormones that help control metabolism, heart rate, blood pressure, and body temperature. Thyroid cancer is a form of cancer that begins in the tissues of the thyroid gland. The major thyroid cancer types are differentiated (including H&uuml;rthle&#8217;s papillary, follicular and papillary), medullary, and anaplastic (aggressive form). Most thyroid cancers are differentiated cancers and when they are observed in the lab, the cells in these cancers appear a lot like normal thyroid tissue<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of the key facts of the Thyroid Cancer Market Report:<\/strong>&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li>The Thyroid Cancer market size is anticipated to grow with a significant <strong>CAGR<\/strong> during the study period<strong> (2019-2032)<\/strong>&nbsp;&nbsp;<\/li>\n<li>As per Surveillance, Epidemiology, and End Results <strong>(SEER)<\/strong>, Thyroid cancer accounts for <strong>43,800<\/strong> new cases in the United States; in 2022&nbsp;<\/li>\n<li>The rate of new cases of thyroid cancer was <strong>15.7 per 100,000<\/strong> men and women per year. The death rate was 0.5 per <strong>100,000<\/strong> men and women per year&nbsp;<\/li>\n<li><strong>Key Thyroid Cancer Companies:<\/strong>&nbsp; Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology, AstraZeneca, and others&nbsp;<\/li>\n<li><strong>Key Thyroid Cancer Therapies:<\/strong>&nbsp; Dabrafenib, Trametinib, AIC 100, LOXO-260, Durvalumaband, tremelimumab, and others&nbsp;<\/li>\n<li>The Thyroid cancer epidemiology based on gender analyzed that women are much more affected by Thyroid Cancer as compared to men<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Get a Free sample for the <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/thyroid-cancer-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Thyroid Cancer Market Report<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key benefits of the Thyroid Cancer Market report:<\/strong><\/p>\n<ol style=\"text-align: justify;\" start=\"1\">\n<li>Thyroid Cancer market report covers a descriptive overview and comprehensive insight of the Thyroid Cancer Epidemiology and Thyroid Cancer market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) &amp; Japan.)<\/li>\n<li>The Thyroid Cancer market report provides insights on the current and emerging therapies.<\/li>\n<li>Thyroid Cancer market report provides a global historical and forecasted market covering drug outreach in 7MM.<\/li>\n<li>The Thyroid Cancer market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Thyroid Cancer market.<\/li>\n<\/ol>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Discover more about therapies set to grab major Thyroid Cancer market share @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/thyroid-cancer-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Thyroid Cancer market forecast<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Epidemiology Segmentation:<\/strong><\/p>\n<p style=\"text-align: justify;\">The Thyroid Cancer market report proffers epidemiological analysis for the study period 2019&ndash;2032 in the 7MM segmented into:<\/p>\n<ul style=\"text-align: justify;\">\n<li>Total Prevalence of Thyroid Cancer<\/li>\n<li>Prevalent Cases of Thyroid Cancer by severity<\/li>\n<li>Gender-specific Prevalence of Thyroid Cancer<\/li>\n<li>Diagnosed Cases of Episodic and Chronic Thyroid Cancer&nbsp;<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Market<\/strong> &nbsp;<\/p>\n<p style=\"text-align: justify;\">The dynamics of the Thyroid Cancer market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Dabrafenib, Trametinib, and others during the forecasted period 2019-2032.&nbsp;<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download the report to understand which factors are driving Thyroid Cancer epidemiology trends @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/thyroid-cancer-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Thyroid Cancer Epidemiological Insights<\/a>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Market Strengths<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>There are lot of approved therapies for thyroid cancer which is a major market mover<\/li>\n<li>The incidence rate of thyroid cancer has increased in the past which has lead to a higher patient pool<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Dabrafenib+Trametinib:<\/strong> Novartis<\/li>\n<li><strong>AIC 100:<\/strong> AffyImmune Therapeutics<\/li>\n<li><strong>LOXO-260:<\/strong> Eli Lilly + LoxoOncology<\/li>\n<li><strong>Durvalumaband tremelimumab:<\/strong> AstraZeneca<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of the Thyroid Cancer Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>Study Period: 2019&ndash;2032<\/strong><\/li>\n<li><strong>Coverage:<\/strong> 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]<\/li>\n<li><strong>Key Thyroid Cancer Companies:<\/strong> Novartis, AffyImmune Therapeutics, Eli Lilly, LoxoOncology, AstraZeneca, and others<\/li>\n<li><strong>Key Thyroid Cancer Therapies:<\/strong> Dabrafenib, Trametinib, AIC 100, LOXO-260, Durvalumaband, tremelimumab, and others<\/li>\n<li><strong>Therapeutic Assessment:<\/strong> Thyroid Cancer current marketed and Thyroid Cancer emerging therapies<\/li>\n<li><strong>Thyroid Cancer Market Dynamics:<\/strong>&nbsp; Thyroid Cancer market drivers and Thyroid Cancer market barriers&nbsp;<\/li>\n<li><strong>Competitive Intelligence Analysis:<\/strong> SWOT analysis, PESTLE analysis, Porter&rsquo;s five forces, BCG Matrix, Market entry strategies<\/li>\n<li><strong>Unmet Needs, KOL&rsquo;s views, Analyst&rsquo;s views, Thyroid Cancer&nbsp; Market Access and Reimbursement&nbsp;<\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Thyroid Cancer Market Opportunities<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>With the increasing global population, the incidence of thyroid cancer has also surged, leading to increased opportunities for research and development<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents<\/strong>&nbsp;<\/p>\n<p style=\"text-align: justify;\">1. Thyroid Cancer Market Report Introduction<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary for Thyroid Cancer<\/p>\n<p style=\"text-align: justify;\">3. SWOT analysis of Thyroid Cancer<\/p>\n<p style=\"text-align: justify;\">4. Thyroid Cancer Patient Share (%) Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Thyroid Cancer Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">6. Thyroid Cancer Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">7. Thyroid Cancer Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Country-Specific Patient Population of Thyroid Cancer&nbsp;<\/p>\n<p style=\"text-align: justify;\">9. Thyroid Cancer Current Treatment and Medical Practices<\/p>\n<p style=\"text-align: justify;\">10. Thyroid Cancer Unmet Needs<\/p>\n<p style=\"text-align: justify;\">11. Thyroid Cancer Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">12. Thyroid Cancer Market Outlook<\/p>\n<p style=\"text-align: justify;\">13. Country-Wise Thyroid Cancer Market Analysis (2019&ndash;2032)<\/p>\n<p style=\"text-align: justify;\">14. Thyroid Cancer Market Access and Reimbursement of Therapies<\/p>\n<p style=\"text-align: justify;\">15. Thyroid Cancer Market drivers<\/p>\n<p style=\"text-align: justify;\">16. Thyroid Cancer Market barriers<\/p>\n<p style=\"text-align: justify;\">17.&nbsp; Thyroid Cancer Appendix<\/p>\n<p style=\"text-align: justify;\">18. Thyroid Cancer Report Methodology<\/p>\n<p style=\"text-align: justify;\">19. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">20. Disclaimer<\/p>\n<p style=\"text-align: justify;\">21. About DelveInsight<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>To know more about Thyroid Cancer treatment, visit @ <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/thyroid-cancer-market?utm_source=abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=gpr\">Thyroid Cancer Medications<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About DelveInsight<\/strong>&nbsp;<\/p>\n<p style=\"text-align: justify;\">DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p style=\"text-align: justify;\">It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_75707.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Gaurav Bora<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=thyroid-cancer-market-to-grow-at-a-substantial-growth-rate-during-the-forecast-period-20222032-delveinsight-key-companies-novartis-affyimmune-therapeutics-eli-lilly-loxooncology\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> Nevada<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=thyroid-cancer-market-to-grow-at-a-substantial-growth-rate-during-the-forecast-period-20222032-delveinsight-key-companies-novartis-affyimmune-therapeutics-eli-lilly-loxooncology\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight\u2019s \u201cThyroid Cancer Market Insights, Epidemiology, and Market Forecast-2032\u2033 report offers an in-depth understanding of Thyroid Cancer, historical and forecasted epidemiology as well as the Thyroid Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/thyroid-cancer-market-to-grow-at-a-substantial-growth-rate-during-the-forecast-period-20222032-delveinsight-key-companies-novartis-affyimmune-therapeutics-eli-lilly-loxooncology_616277.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[447,405,417,406,423],"tags":[],"class_list":["post-616277","post","type-post","status-publish","format-standard","hentry","category-Education","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-Professional-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/616277","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=616277"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/616277\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=616277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=616277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=616277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}